Skip to Content Facebook Feature Image

Emaar Contributed Over US$ 1 Billion to Elevate Dubai's Global Brand and Visitor Experience

Business

Emaar Contributed Over US$ 1 Billion to Elevate Dubai's Global Brand and Visitor Experience
Business

Business

Emaar Contributed Over US$ 1 Billion to Elevate Dubai's Global Brand and Visitor Experience

2025-04-22 09:20 Last Updated At:09:35

DUBAI, UAE, April 22, 2025 /PRNewswire/ -- Emaar, the master developer behind Dubai's most iconic landmarks, has invested over US$ 1 billion in shaping and enhancing the city's global identity. This cumulative contribution underscores the company's long-standing commitment to reinforcing Dubai's international standing through cutting-edge experiences, vibrant cultural platforms, and landmark social infrastructure.

From creating and operating Dubai Fountain—the world's largest choreographed fountain—and producing the internationally acclaimed New Year's Eve celebrations at Burj Khalifa, to enabling the launch and continued success of Dubai Opera as the region's cultural epicentre, Emaar has consistently raised the bar in enriching Dubai's urban and cultural fabric.

These signature experiences are sustained and enhanced through ongoing annual investments exceeding US$ 50 million, covering not only the operation and maintenance of key attractions, but also the evolution of immersive technologies and entertainment formats. This includes the modernisation of Burj Khalifa's façade with next-generation lighting and projection systems, enabling captivating narratives that reach millions of viewers globally.

In addition to its physical contributions, Emaar continues to champion inclusive growth and community wellbeing. Through the Emaar Foundation, the company supports a wide range of local causes—from charitable housing and development programmes to national sports and cultural sponsorships—demonstrating its integral role in nurturing both city and society.

"Emaar's journey has always been rooted in a vision that transcends construction—it is about crafting experiences that inspire, unite, and leave a lasting impact," said Mr. Mohamed Alabbar, Founder of Emaar. "Our investments are a testament to our belief in Dubai's limitless potential, and we are proud to play a key role in defining its global narrative."

Emaar's commitment to excellence, innovation, and community empowerment continues to drive progress, shaping Dubai's future as a leading global hub. With bold ideas and sustained contributions, the company is poised to play an even greater role in defining the city's next chapter as it strives to become one of the most admired destinations in the world.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Emaar Contributed Over US$ 1 Billion to Elevate Dubai's Global Brand and Visitor Experience

Emaar Contributed Over US$ 1 Billion to Elevate Dubai's Global Brand and Visitor Experience

KUALA LUMPUR, Malaysia, May 2, 2025 /PRNewswire/ -- As Southeast Asia's pharmaceutical industry rapidly evolves—driven by regulatory harmonization, innovation, and growing healthcare demand—CPHI South East Asia 2025 provides a vital platform to connect with regional stakeholders, showcase breakthroughs, and unlock business opportunities across the ASEAN region.

Taking place for the first time in Kuala Lumpur, Malaysia, from 16–18 July 2025, the event will bring together 8,000+ professionals, 400+ global exhibitors, and curated buyers from across Asia and beyond—positioning it as the region's most impactful pharma event.

Unlock Growth Across ASEAN's Pharma Markets

From Indonesia, Thailand, Vietnam, the Philippines to Malaysia, Southeast Asia is one of the world's most dynamic pharmaceutical regions. Governments are investing in local manufacturing, reforming regulatory systems, and opening doors to international partnerships.

Malaysia, as this year's host, plays a central role in this growth. [1]The country's pharmaceutical market is expected to rise from RM11.2 billion in 2022 to RM15.5 billion by 2027, supported by the New Industrial Master Plan (NIMP) 2030, which incentivizes the production of APIs, biologics, and vaccines.

[2] Strategically located between Singapore and Indonesia, Malaysia offers streamlined access to regional distributors, CDMOs, and packaging partners—making Kuala Lumpur a strategic gateway to ASEAN-wide expansion.

Source: 1. MIDA, MITI Malaysia

2. ASEAN Pharmaceutical Industry Report

At CPHI South East Asia 2025, you'll be able to:

Event Highlights

Venue: MITEC, Kuala Lumpur
Dates: 16–18 July 2025
Explore more at:  https://www.cphi.com/sea

Register to visit at:  https://cphisea.imasia-passport.com/

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

CPHI South East Asia 2025: Your gateway to ASEAN's expanding pharmaceutical landscape

CPHI South East Asia 2025: Your gateway to ASEAN's expanding pharmaceutical landscape

Recommended Articles
Hot · Posts